Tommy Martinsson

发表

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma

Birgitta Lannering, P. Åman, M. Tisell, 2017, PloS one.

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.

Per Kogner, Tommy Martinsson, P. Kogner, 2013, International journal of oncology.

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

Annika Bergman, Staffan Nilsson, Kaisa Thorell, 2009, BMC Medical Genomics.

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

Staffan Nilsson, Jonas Abrahamsson, Helena Carén, 2010, Proceedings of the National Academy of Sciences.

Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis.

Christoph Bartenhagen, Matthias Fischer, Tanmoy Mondal, 2018, Cancer cell.

A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma

Ruth Ladenstein, Gudrun Schleiermacher, Mario Drobics, 2011, Clinical Cancer Research.

The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.

Gaurav Kumar Pandey, Leming Shi, Erik Larsson, 2014, Cancer cell.

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

Catherine Morrissey, John D Minna, J. Minna, 2003, Oncogene.

Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2

Tommy Martinsson, T. Martinsson, K. Ejeskär, 2007, Genes, chromosomes & cancer.